Compare Honeywell International Inc (HON) vs Johnson & Johnson (JNJ) Price & Performance

Honeywell (HON) trades at $235.01, down 3.26% amid bearish technical signals and recent growth guidance concerns. The stock shows strong fundamentals with a P/E of 8.85, net margin of 21.58%, and consistent earnings beats. Recent corporate actions include a 2:1 reverse stock split and dividend payments, while business divestitures aim to sharpen focus on automation. Cash flow remains positive at $1.92B for 2025, though 2026 projections indicate a net outflow.

Outlook is mixed: valuation appears attractive with analyst consensus target of $320.54, but near-term risks include bearish technicals, debt-to-asset ratio rising to 47.66%, and potential growth deceleration. Investors may find long-term value if automation segments drive recovery, though volatility from recent spinoff underperformance warrants caution.

Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.

Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.